Monday, June 13, 2016

UPDATE 1-Marinus tanks as adult focal onset seizure drug fails late stage

June 13 (Reuters) - Marinus Pharmaceuticals Inc

said it plans to stop development of its treatment for

drug-resistant focal onset seizures in adults after it failed a

late-stage trial, sending the...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)